Abstract
Since its discovery in 1983, Human Immunodeficiency Virus-1 (HIV) infection has resulted in the death of several million people worldwide. Control of the spread of HIV infections is one of the major concerns of the scientific community today. This retrovirus houses a genome encoding three viral structural proteins: group-specific antigen, polymerase and envelope. The envelope gp120 binds to cell surface receptors on susceptible target cells in the host. Although HIV is known to infect various cell types, cells expressing the CD4 receptor support high levels of viral replication in vivo. Gastrointestinal complications are commonly seen in patients with HIV-1 infections progressing to AIDS. Recent studies have shown that HIV causes massive disruption of the Gut Associated Lymphoid Tissue (GALT) very early in infection. Intestinal dysfunction is often not resolved despite the success of HAART in improving the clinical status of these patients. GALT supports robust viral replication in mucosal memory CD4+ T cells during primary HIV infection, leading to a severe depletion of the CD4+ T cells which persists through all stages of HIV infection in the absence of therapeutic interventions. Functional genomic analysis of host responses to HIV shows that molecular processes regulating inflammation and immune activation are dominantly expressed in GALT of therapy-nave HIV-1 infected patients with a progressive clinical course. Heterosexual transmission is the primary mode for the spread of HIV infection and the virus gains entry through mucosal surfaces and infects susceptible target cells. Since a majority of new infections are acquired through the mucosal route, induction of mucosal immunity is an important factor in vaccine design.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
2007, AIDS Alert, 22, suppl 1.
Evian C, Fox M, MacLeod W, Slotow SJ, & Rosen S. 2004, S Afr Med J, 94, 125.
[CDC]. 2006, Centers for Disease Control and Prevention [CDC]HIV/AIDS Surveillance Report, Volume 16.
Padma TV. 2005, Nat Med, 11, 695.
Qian HZ, Vermund SH, & Wang N. 2005, Sex Transm Infect, 81, 442.
Ruxrungtham K, Brown T, & Phanuphak P. 2004, Lancet, 364, 69.
Sharma VK & Khandpur S. 2004, Natl Med J India, 17, 310.
Tucker JD, Henderson GE, Wang TF, Huang YY, Parish W, Pan SM, Chen XS, & Cohen MS. 2005, Aids, 19, 539.
Kriebs JM. 2002, J Perinat Neonatal Nurs, 16, 1.
Regez RM, Kleipool AE, Speekenbrink RG, & Frissen PH. 2005, Int J STD AIDS, 16, 671.
Wig N. 2003, Indian J Med Sci, 57, 192.
Baggaley RF, Boily MC, White RG, & Alary M. 2006, Aids, 20, 805.
Zou S, Musavi F, Notari EPt, Fujii KE, & Dodd RY. 2005, Transfusion, 45, 1593.
Spira S, Wainberg MA, Loemba H, Turner D, & Brenner BG. 2003, J Antimicrob Chemother, 51, 229.
Hughes A & Corrah T. 1990, Blood Rev, 4, 158.
Kuznetsov YG, Victoria JG, Robinson WE, Jr., & McPherson A. 2003, J Virol, 77, 11896.
Russell RS, Liang C, & Wainberg MA. 2004, Retrovirology, 1, 23.
Ott DE, Coren LV, Kane BP, Busch LK, Johnson DG, Sowder RC, 2nd, Chertova EN, Arthur LO, & Henderson LE. 1996, J Virol, 70, 7734.
Zhu P, Liu J, Bess J, Jr., Chertova E, Lifson JD, Grise H, Ofek GA, Taylor KA, & Roux KH. 2006, Nature,441, 847.
Nguyen DH & Hildreth JE. 2000, J Virol, 74, 3264.
Campbell GR, Pasquier E, Watkins J, Bourgarel-Rey V, Peyrot V, Esquieu D, Barbier P, de Mareuil J, Braguer D, Kaleebu P, et al. 2004, J Biol Chem, 279, 48197.
Khan MA, Aberham C, Kao S, Akari H, Gorelick R, Bour S, & Strebel K. 2001, J Virol, 75, 7252.
Goncalves J & Santa-Marta M. 2004, Retrovirology, 1, 28.
Garcia JV & Miller AD. 1991, Nature, 350, 508.
Bukrinsky M & Adzhubei A. 1999, Rev Med Virol, 9, 39.
Neil SJ, Eastman SW, Jouvenet N, & Bieniasz PD. 2006, PLoS Pathog, 2, e39.
Binette J, Dube M, Mercier J, Halawani D, Latterich M, & Cohen EA. 2007, Retrovirology, 4, 75.
Ullrich R, Schmidt W, Zippel T, Schneider T, Zeitz M, & Riecken EO. 1998, Pathobiology, 66, 145.
Suresh P & Wanchu A. 2006, J Postgrad Med, 52, 210.
Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, & Jeang KT. 2000, Proc Natl Acad Sci USA, 97, 11466.
Luban J, Bossolt KL, Franke EK, Kalpana GV, & Goff SP. 1993, Cell, 73, 1067.
Bouyac-Bertoia M, Dvorin JD, Fouchier RA, Jenkins Y, Meyer BE, Wu LI, Emerman M, & Malim MH. 2001, Mol Cell, 7, 1025.
Mellors JW, Rinaldo CR, Jr., Gupta P, White RM, Todd JA, & Kingsley LA. 1996, Science, 272, 1167.
Tough DF & Sprent J. 1995, Immunol Res, 14, 1.
Pantaleo G & Fauci AS. 1996, Annu Rev Microbiol, 50, 825.
Lederman MM. 2001, AIDS, 15 Suppl 2, S11.
Mackewicz CE, Yuan J, Tran P, Diaz L, Mack E, Selsted ME, & Levy JA. 2003, AIDS, 17, F23.
Blumberg RS, Yockey CE, Gross GG, Ebert EC, & Balk SP. 1993, J Immunol, 150, 5144.
Ebert EC. 1993, Cell Immunol, 147, 331.
Boismenu R & Havran WL. 1994, Science, 266, 1253.
Havran WL & Boismenu R. 1994, Curr Opin Immunol, 6, 442.
Kang YS, Calvanico NJ, & Tomasi TB, Jr. 1974, J Immunol, 112, 162.
Tomasi TB & Grey HM. 1972, Prog Allergy, 16, 81.
Czerkinsky C, Quiding M, Eriksson K, Nordstrom I, Lakew M, Weneras C, Kilander A, Bjorck S, Svennerholm AM, Butcher E, et al. 1995, Adv Exp Med Biol, 371B, 1409.
Eriksson K, Kilander A, Hagberg L, Norkrans G, Holmgren J, & Czerkinsky C. 1995, Adv Exp Med Biol, 371B, 1011.
Mestecky J. 1987, J Clin Immunol, 7, 265.
Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, Carswell JW, Kirya GB, Bayley AC, Downing RG, Tedder RS, Clayden SA, et al. 1985, Lancet, 2, 849.
Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, Prindiville T, & Dandekar S. 2008, J Virol, 82, 538.
Verhoef K, Tijms M, & Berkhout B. 1997, Nucleic Acids Res, 25, 496.
Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, & Dandekar S. 2006, J Virol, 80, 8236.
Dandekar S. 2007, Curr HIV/AIDS Rep, 4, 10.
Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, & Roederer M. 2005, Nature, 434, 1093.
Picker LJ. 2006, Curr Opin Immunol, 18, 399.
Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, & Dandekar S. 2003, J Virol, 77, 11708.
Grossman Z, Meier-Schellersheim M, Paul WE, & Picker LJ. 2006, Nat Med, 12, 289.
Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, & Markowitz M. 2004, J Exp Med, 200, 761.
Haase AT. 2005, Nat Rev Immunol, 5, 783.
Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, Shet A, Low A, Mohri H, Boden D, et al. 2007, J Virol, 81, 599.
Mehandru S, Tenner-Racz K, Racz P, & Markowitz M. 2005, J Allergy Clin Immunol, 116, 419.
George MD, Reay E, Sankaran S, & Dandekar S. 2005, J Virol, 79, 2709.
Heise C, Vogel P, Miller CJ, Halsted CH, & Dandekar S. 1993, Am J Pathol, 142, 1759.
Lackner AA & Veazey RS. 2007, Annu Rev Med, 58, 461.
Veazey RS, Marx PA, & Lackner AA. 2001, Trends Immunol, 22, 626.
Hirsch VM & Lifson JD. 2000, Adv Pharmacol, 49, 437.
Douek D. 2007, Top HIV Med, 15, 114.
Kotler DP. 2005, AIDS, 19, 107.
Sankaran S, Guadalupe M, Reay E, George MD, Flamm J, Prindiville T, & Dandekar S. 2005, Proc Natl Acad Sci USA, 102, 9860.
Brenchley JM, Price DA, & Douek DC. 2006, Nat Immunol, 7, 235.
Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. 2006, Nat Med, 12, 1365.
Poles MA, Boscardin WJ, Elliott J, Taing P, Fuerst MM, McGowan I, Brown S, & Anton PA. 2006, J Acquir Immune Defic Syndr, 43, 65.
Coffin JM. 1996, AIDS, 10 Suppl 3, S75.
Li Q, Schacker T, Carlis J, Beilman G, Nguyen P, & Haase AT. 2004, J Infect Dis, 189, 572.
Cohen OJ & Fauci AS. 2001, Adv Intern Med, 46, 207.
Sanchez R, Portilla J, Gimeno A, Boix V, Llopis C, Sanchez-Paya J, Merino E, de la Sen ML, Munoz C, Reus S, et al. 2006, J Infect, 22, Suppl 1.
Coates JA, Cammack N, Jenkinson HJ, Jowett AJ, Jowett MI, Pearson BA, Penn CR, Rouse PL, Viner KC, & Cameron JM. 1992, Antimicrob Agents Chemother, 36, 733.
De Clercq E. 1995, J Med Chem, 38, 2491.
Hazen R & Lanier ER. 2003, J Acquir Immune Defic Syndr, 32, 255.
Pollard RB, Peterson D, Hardy D, Pottage J, Murphy RL, Gathe J, Beall G, Rutkievicz V, Reynolds L, Cross AP, et al. 1999, J Acquir Immune Defic Syndr, 22, 39.
Ren J, Esnouf RM, Hopkins AL, Warren J, Balzarini J, Stuart DI, & Stammers DK. 1998, Biochemistry, 37, 14394.
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, et al. 1999, Lancet, 354, 795.
Marseille E, Kahn JG, & Saba J. 1998, Aids, 12, 939.
Venaud S, Yahi N, Fehrentz JL, Guettari N, Nisato D, Hirsch I, & Chermann JC. 1992, Res Virol, 143, 311.
Gulick RM, Ribaudo HJ, Shikuma CM, Lalama C, Schackman BR, Meyer WA, 3rd, Acosta EP, Schouten J, Squires KE, Pilcher CD, et al. 2006, Jama, 296, 769.
Struble K, Murray J, Cheng B, Gegeny T, Miller V, & Gulick R. 2005, Aids, 19, 747.
Blankson JN. 2005, AIDS Read, 15, 245.
Mauskopf J, Kitahata M, Kauf T, Richter A, & Tolson J. 2005, J Acquir Immune Defic Syndr, 39, 562.
Julg B & Goebel FD. 2006, Infection, 34, 186.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Dandekar, S., Sankaran, S., Glavan, T. (2008). HIV and the Mucosa: No Safe Haven. In: Vajdy, M. (eds) Immunity Against Mucosal Pathogens. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8412-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8412-6_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8411-9
Online ISBN: 978-1-4020-8412-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)